NanoVector licenses biologic nanoparticle drug-delivery technology

12/4/2008 | Nanotechnology Now

NanoVector has licensed a plant-virus nanoparticle drug-delivery system designed for the selective targeting of tumors and the intracellular delivery of anti-cancer drugs. The system, which was developed by researchers at North Carolina State University, could help improve the efficacy of cytotoxic drugs and reduce their adverse side effects.

View Full Article in:

Nanotechnology Now

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX